These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)]. Nadar SK; Blann A; Beevers DG; Lip GY J Intern Med; 2005 Oct; 258(4):336-43. PubMed ID: 16164572 [TBL] [Abstract][Full Text] [Related]
6. Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromes. Lee KW; Lip GY; Blann AD Circulation; 2004 Oct; 110(16):2355-60. PubMed ID: 15302795 [TBL] [Abstract][Full Text] [Related]
7. [Assessment of the selected, late phase of angiogenesis factors' concentration in colorectal cancer patients]. Wieloch M; Swiatkowska M; Libiszewski M; Hedayati M; Drozda R; Kołomecki K Pol Merkur Lekarski; 2009 Dec; 27(162):466-9. PubMed ID: 20120708 [TBL] [Abstract][Full Text] [Related]
8. Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade. Lip PL; Chatterjee S; Caine GJ; Hope-Ross M; Gibson J; Blann AD; Lip GY Br J Ophthalmol; 2004 Dec; 88(12):1543-6. PubMed ID: 15548809 [TBL] [Abstract][Full Text] [Related]
9. Plasma concentration of angiopoietin-1, angiopoietin-2 and Tie-2 in cervical cancer. Kopczyńska E; Makarewicz R; Biedka M; Kaczmarczyk A; Kardymowicz H; Tyrakowski T Eur J Gynaecol Oncol; 2009; 30(6):646-9. PubMed ID: 20099495 [TBL] [Abstract][Full Text] [Related]
10. Serum levels of angiopoietin-1, angiopoietin-2, and their receptor tie-2 in patients with nonsmall cell lung cancer during chemotherapy. Naumnik W; Chyczewska E; Ossolinska M Cancer Invest; 2009 Aug; 27(7):741-6. PubMed ID: 19340656 [TBL] [Abstract][Full Text] [Related]
11. Plasma angiopoietin-1, angiopoietin-2 and Tie-2 in breast and prostate cancer: a comparison with VEGF and Flt-1. Caine GJ; Blann AD; Stonelake PS; Ryan P; Lip GY Eur J Clin Invest; 2003 Oct; 33(10):883-90. PubMed ID: 14511360 [TBL] [Abstract][Full Text] [Related]
12. The association of the angiopoietin/Tie-2 system with the development of metastasis and leukocyte migration in neuroendocrine tumors. Figueroa-Vega N; Díaz A; Adrados M; Alvarez-Escolá C; Paniagua A; Aragonés J; Martín-Pérez E; Leskela S; Moreno-Otero R; González-Amaro R; Marazuela M Endocr Relat Cancer; 2010 Dec; 17(4):897-908. PubMed ID: 20696814 [TBL] [Abstract][Full Text] [Related]
13. Potential role of soluble angiopoietin-2 and Tie-2 in patients with inflammatory bowel disease. Koutroubakis IE; Xidakis C; Karmiris K; Sfiridaki A; Kandidaki E; Kouroumalis EA Eur J Clin Invest; 2006 Feb; 36(2):127-32. PubMed ID: 16436095 [TBL] [Abstract][Full Text] [Related]
14. Significant decrease in maternal serum concentrations of angiopoietin-1 and -2 after delivery. Keikkala E; Hytinantti T; Wathén KA; Andersson S; Vuorela P Acta Obstet Gynecol Scand; 2012 Aug; 91(8):917-22. PubMed ID: 22583143 [TBL] [Abstract][Full Text] [Related]
15. Angiopoietin-2 is related to tumor angiogenesis in gastric carcinoma: possible in vivo regulation via induction of proteases. Etoh T; Inoue H; Tanaka S; Barnard GF; Kitano S; Mori M Cancer Res; 2001 Mar; 61(5):2145-53. PubMed ID: 11280779 [TBL] [Abstract][Full Text] [Related]
16. Maternal serum angiopoietin-1 and -2 and tie-2 in early pregnancy ending in preeclampsia or intrauterine growth retardation. Leinonen E; Wathén KA; Alfthan H; Ylikorkala O; Andersson S; Stenman UH; Vuorela P J Clin Endocrinol Metab; 2010 Jan; 95(1):126-33. PubMed ID: 19875484 [TBL] [Abstract][Full Text] [Related]
17. Marrow angiogenesis-associated factors as prognostic biomarkers in patients with acute myelogenous leukaemia. Lee CY; Tien HF; Hu CY; Chou WC; Lin LI Br J Cancer; 2007 Oct; 97(7):877-82. PubMed ID: 17848952 [TBL] [Abstract][Full Text] [Related]
19. The angiopoietin/Tie-2 system in proliferative sickle retinopathy: relation to vascular endothelial growth factor, its soluble receptor Flt-1 and von Willebrand factor, and to the effects of laser treatment. Mohan JS; Lip PL; Blann AD; Bareford D; Lip GY Br J Ophthalmol; 2005 Jul; 89(7):815-9. PubMed ID: 15965157 [TBL] [Abstract][Full Text] [Related]
20. Changes in plasma vascular endothelial growth factor, angiopoietins, and their receptors following surgery for breast cancer. Caine GJ; Stonelake PS; Lip GY; Blann AD Cancer Lett; 2007 Apr; 248(1):131-6. PubMed ID: 16891056 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]